Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier

By Kastin Abba   Akerstrom Victoria   Pan Weihong  

Journal of Molecular Neuroscience, Vol. 18, Iss. 1-2, 2002-02 ,pp. : 7-14

Humana Press, Inc

Access to resources Recommend Favorite

The Complex Actions of Statins in Brain and their Relevance for Alzheimer’s Disease Treatment: An Analytical Review

By  

Current Alzheimer Research, Vol. 11, Iss. 9, 2014-11 ,pp. : 817-833

Bentham Science Publishers

Access to resources Recommend Favorite

Decreased Glucagon-Like Peptide-1 Receptor Immunoreactivity in the Dentate Granule Cell Layer from Adult in the Gerbil Hippocampus

By Lee Choong  

Cellular and Molecular Neurobiology, Vol. 31, Iss. 3, 2011-04 ,pp. : 345-350

Springer Publishing Company

Access to resources Recommend Favorite

Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells

By Nakagawa A.   Satake H.   Nakabayashi H.   Nishizawa M.   Furuya K.   Nakano S.   Kigoshi T.   Nakayama K.   Uchida K.  

Autonomic Neuroscience, Vol. 110, Iss. 1, 2004-01 ,pp. : 36-43

Elsevier

Access to resources Recommend Favorite

Structure and permeability changes of the blood-brain barrier in APP/PS1 mice: an Alzheimer's disease animal model

By Wang Yulin   Liu Jing   Zhang Zhongmin   Wang Xiaoli   Zhang Chaodong  

Neurochemical Journal, Vol. 5, Iss. 3, 2011-09 ,pp. : 220-222

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite